Coexistent Rosai Dorfman disease and Langerhans cell histiocytosis in an Orbital mass: A Case Report. Issue 3 (May 2023)

• Record Type: Journal Article
• Authors: Rastogi, Anju; Jaisingh, Kirti; Rajurkar, Ketaki; Saran, Ravindra Kumar; Singh, Meeta; Baindur, Siddharth; Singiri, Deepthi; Gaonker, Tanvi
• Is Part Of: European journal of ophthalmology. Volume 33:Issue 3(2023)
• Page Start: NP60
• Page End: NP65
• Publication Date: 2023-05
• Subjects: Rosai Dorfman disease -- Langerhans cell histiocytosis -- histiocytosis -- co-occurrence; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; 617.7005
• DOI: 10.1177/11206721221083727
• Languages: English
• ISSNs: 1120-6721

Abstract

Introduction: Rosai Dorfman disease (RDD) is a rare benign histiocytic proliferative disorder of lymph node sinuses. Langerhans cell histiocytosis (LCH) is a solitary or multisystem clonal proliferation of abnormal dendritic cells (Langerhans cells) with varied presentations. The co-occurrence of these two entities is quite rare. Case description: A six-year-old boy presented with multiple mass lesions in the neck since two years and a nodular lesion in right upper eyelid for the past 4 months. He was diagnosed with tubercular lymphadenitis 2 years back, and was given a course of anti-tubercular therapy (ATT) elsewhere. No improvement was seen. Fine needle aspiration cytology (FNAC) of the cervical lymph nodes revealed reactive lymphadenitis while lymph node biopsy showed features of RDD. Excision biopsy of the orbital mass showed features of both RDD and LCH. The patient was started on tablet prednisolone. Six months later, complete resolution of lymph node enlargement and remaining orbital mass was noted. Post operative contrast enhanced Magnetic Resonance Imaging of head and neck was normal. Conclusion: The coexistence of RDD and LCH may be a result of divergent differentiation from a common lineage or a de novo phenotypic evolution.